论文部分内容阅读
2017年第一季度医药板块整体企稳回升。随着新版医保药品目录的公布和推进,1.5万亿的医药市场也有望借此迎来重构。从2016年下半年开始,医药行业各项政策不断,今年以来随着各项细则不断公布,行业迈入政策落地期。未来医药行业的竞争格局有望发生重大变化,但影响行业发展的负面因素冲击也有所缓解,医药板块将很快迎来行业拐点。行业稳定性增长据悉,2017年第一季度医药板块整体企稳回升。2017年1~2月医药制造业主营业务收入为4148.5亿
In the first quarter of 2017, the pharmaceutical sector overall stabilized and recovered. With the announcement and promotion of the new version of Medicare drug list, the 1.5 trillion pharmaceutical market is also expected to usher in the reconstruction. From the second half of 2016, various policies in the pharmaceutical industry will continue. With the continuous promulgation of various rules this year, the industry has entered the policy period. The competition pattern of the pharmaceutical industry in the future is expected to undergo significant changes. However, the negative impact on the development of the industry will also be eased. The pharmaceutical sector will soon usher in an industry turning point. Industry stability growth It is reported that in the first quarter of 2017 the pharmaceutical sector stabilized and rebounded. From January to February 2017, revenue from main operations of pharmaceutical manufacturing industry was 414.85 billion yuan